Peroxisome proliferator-activated receptor (PPAR) γ: A new target for the treatment of inflammatory bowel disease;Le recepteur active par les proliferateurs des peroxysomes (PPAR) γ: Une nouvelle cible therapeutique pour le traitement des maladies inflammatoires chroniques de l'intestin

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 8-9, 2000, Pages 719-724

  Dubuquoy, Laurent ^a,b   Bourdon, Caroline ^a   Peuchmaur, Michel ^c   Leibowitz, Mark D ^d   Nutten, Sophie ^a   Colombel, Jean Frédéric ^a   Auwerx, Johan ^e   Desreumaux, Pierre ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d LIGAND PHARMACEUTICALS INC   (United States)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cytokines; Inflammatory bowel diseases; Nuclear receptors; PPAR ; Therapeutic research

Indexed keywords

INTERLEUKIN 1; MESSENGER RNA; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; CELL RECEPTOR; PEROXIDASE; TRANSCRIPTION FACTOR; TRINITROBENZENESULFONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ASSAY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCORING SYSTEM; TREATMENT OUTCOME; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; COLON; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; INTESTINE MUCOSA; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; COLITIS; COLON; INTERLEUKIN-1; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; PEROXIDASE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034242215     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
2. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
3. Peroxisome proliferator activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
4. Peroxisome proliferator-activated receptors, orphans with ligands and functions
5. 2 is a ligand for the adipocyte determination factor PPARγ
6. The organization, promoter analysis, and expression of the human PPARγ gene
7. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
8. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
9. PPARγ agonist inhibits interleukin-8 production by the human colon epithelial cell line HT-29
10. Antibodies to interleukin 12 abrogate established experimental colitis in mice
11. Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats
12. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APC(Min)/+mice
13. Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effects
14. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
15. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulfonic acid induced colitis
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
18. T helper type I/T helper type 2 cytokines and T cell death: Preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons
19. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
20. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
21. Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation
22. The mechanism of altered neural function in a rat model of acute colitis
23. Cytokines et anti-cytokines dans les maladies inflammatoires chroniques de l'intestin
24. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
25. PPARγ agonists inhibit production of monocyte inflammatory cytokines
26. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
27. Ulcerative colitis is associated with a mucosal deficit in PPARγ
28. Thiazolidinediones: An update
29. Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration